Lipid Nanoparticles as Carriers for RNAi against Viral Infections: Current Status and Future Perspectives

The efforts made to develop RNAi-based therapies have led to productive research in the field of infections in humans, such as hepatitis C virus (HCV), hepatitis B virus (HBV), human immunodeficiency virus (HIV), human cytomegalovirus (HCMV), herpetic keratitis, human papillomavirus, or influenza vi...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Torrecilla, Josune, Rodríguez-Gascón, Alicia, Solinís, María Ángeles, del Pozo-Rodríguez, Ana
Natura: Artigo
Lingua:Inglês
Pubblicazione: Hindawi Publishing Corporation 2014
Soggetti:
Review Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4145386/
https://ncbi.nlm.nih.gov/pubmed/25184135
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2014/161794
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi